UGI CORPORATION

UGI

CIK 0000884614 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2.08B
↑+2.6% +$53Mvs FY2024 (Q4)
Operating Income
$454M
↓-6.8% -$33Mvs FY2024 (Q4)
Net Income
$297M
↓-20.8% -$78Mvs FY2024 (Q4)
Gross Profit
$1.07B
↓-3.3% -$36Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
20/100
  • Profitability
    23ROIC 9.6% (10% = solid, 20%+ = moat)
  • Liquidity
    20Current Ratio 0.89 (above 1.5 = solid)
  • Leverage
    30D/E 1.39 (under 0.5 = conservative)
  • Efficiency
    21Asset Turnover 0.48x (1.0+ = capital-efficient)
  • Growth
    25Revenue YoY +2.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 21.8% · trend -8.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project UGI's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$30.61
Total enterprise IV
$6.71B
Diluted shares
0.22B
Terminal PV
$4.86B (72% of total)
Year-5 FCF
$573M
YearProjected FCFDiscounted PV
+1$421M$383M
+2$455M$376M
+3$491M$369M
+4$531M$362M
+5$573M$356M
Terminal$7.83B$4.86B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$847M
investment in PP&E
Dividends paid (TTM)
$322M
cash returned to holders
Stock buybacks (TTM)
$45M
share count reduction

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$15.81B
everything owned
Total liabilities
$10.80B
everything owed
Stockholders' equity
$5.00B
shareholder claim
Net debt
$6.40B
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+2.6% +$53M
$2.08B
Net Income↓-20.8% -$78M
$297M
Free Cash Flow↓-229.8% -$108M
$-155M
Operating Margin↓-2.2pts
21.8%

Drill down